Charming Medical Limited Class A Ordinary Shares

MCTA | NASDAQ

$29.36

$0.00 (0.00%)

Nov 2, 2026, 10:37 AM ET · Market open

TTM Period Ending	Q4 2024 Mar 31, 2025	Q2 2024 Sep 30, 2024	Q4 2023 Mar 31, 2024
Cash & Equivalents	816.77K	2.69M	2.1M
Short-Term Investments	1.94M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	700.64K	582.64K	81.44K
Receivables	579.09K	587.93K	1.54M
Inventory	26.8K	34.15K	28.15K
Other Current Assets	n/a	n/a	n/a
Total Current Assets	3.37M	3.31M	3.67M
Property-Plant & Equipment	1.21M	1.3M	921.86K
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	1.99M	2.06M	1.21M
Total Assets	5.36M	5.37M	4.88M
Account Payables	3.48K	42.52K	n/a
Deferred Revenue	3.46M	4.18M	4.5M
Short-Term Debt	314.23K	381.04K	442.61K
Other Current Liabilities	n/a	n/a	n/a
Total Current Liabilities	4.95M	5.6M	5.88M
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	358.03K	459.59K	148.25K
Total Liabilities	5.31M	6.06M	6.03M
Total Debt	1.16M	1.35M	961.38K
Book Value	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a
Common Stock	1.53K	1.53K	1.53K
Retained Earnings	119.44K	-610.83K	-1.08M
Comprehensive Income	-3.57K	-3.6K	205
Shareholders Equity	49.24K	-681.06K	-1.08M
Total Investments	1.94M	n/a	n/a